プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Verena S.に依頼

Austria

PhD Medical Scientist | Scientific Writing, Study Interpretation & Medical Fact-Checking | Oncology

プロフィール概要

I am a PhD-trained medical scientist specializing in evidence-based science communication and medical writing. With expertise in oncology and clinical research, I translate complex medical data into clear, accurate, and responsible content for healthcare and life science organizations. My services include clinical study summaries, disease awareness materials, literature reviews, and educational articles tailored to professional and informed audiences. I also provide targeted support for smaller, high-precision tasks such as scientific editing, fact-checking, abstract rewriting, and interpretation of clinical study data. These services are particularly suited for projects requiring accuracy, clarity, and a strong scientific background within a limited timeframe. I provide scientific and editorial services only. Final medical and regulatory responsibility remains with the client.

専門分野

• ☆ Oncology
• ☆ Medical Sciences

サービス

• Writing
• Research

Writing Clinical Trial Documentation, Medical Writing, Newswriting, General Proofreading & Editing, Translation

Research Market Research

職務経験

Medical Manager

Institut Allergosan

5月 2018 - 現在

Scientist

Medical University of Graz

5月 2013 - 12月 2017

学歴

Doctoral Program

Clinical Department of Oncology

10月 2013 - 12月 2016

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Verena Stiegelbauer, Lisa-Maria Schanza, Maximilian Seles, Michael Stotz, Johannes Fosselteder, Georg Hutterer, Martin Pichler (2017). MicroRNAs Associated with Von Hippel–Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review . International Journal of Molecular Sciences.

Verena Stiegelbauer, Georg Richtig, Ariane Aigelsreiter, Daniela Schwarzenbacher, Anna Lena Ress, Jan Basri Adiprasito, Gerald Hoefler, Silvia Schauer, Tobias Kiesslich, Peter Kornprat, et al. (2017). SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types . PLOS ONE.

Verena Stiegelbauer, Petra Vychytilova-Faltejskova, Michael Karbiener, Anna-Maria Pehserl, Andreas Reicher, Margit Resel, Ellen Heitzer, Cristina Ivan, Marc Bullock, Hui Ling, et al. (2017). miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5 . Clinical Cancer Research.

Verena Stiegelbauer, Alexander J.A. Deutsch, Beate Rinner, Martin Pichler, Katharina Prochazka, Katrin Pansy, Marco Bischof, Karoline Fechter, Stefan Hatzl, Julia Feichtinger, et al. (2017). NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes . Cancer Research.

Verena Stiegelbauer, Martin Pichler, Petra Vychytilova-Faltejskova, Cristina Ivan, Hui Ling, Elke Winter, Xinna Zhang, Matthew Goblirsch, Annika Wulf-Goldenberg, Masahisa Ohtsuka, et al. (2017). Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis . Clinical Cancer Research.

Verena Stiegelbauer, Hui Ling, Karen Pickard, Cristina Ivan, Claudio Isella, Mariko Ikuo, Richard Mitter, Riccardo Spizzo, Marc D Bullock, Cornelia Braicu, et al. (2016). The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis . Gut.

Verena Stiegelbauer (2014). MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer . World Journal of Gastroenterology.